News | September 09, 2007

Signalife Launches Sales of Ambulatory Heart Monitor

September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular monitor.
In private meetings throughout the United States over the next 10 days, the company's cardiovascular experts and Signalife's technology team will present the technologies to the several hospitals, facilities and physician-groups.
"We will be visiting more than a dozen hospitals with thousands of beds and hundreds of physicians, beginning now, in cities nationwide," said Lowell Harmison, CEO of Signalife.

For more information: www.signalife.com

Overlay Init